title: Future acceptance of an artificial pancreas in adults with type 1 diabetes.
abstract: BACKGROUND
  The purpose of this study was to examine future acceptance of an artificial pancreas (AP) and its perceived usefulness, ease of use, and trust in the device.
  
  
  METHODS
  A questionnaire, based on the Technology Acceptance Model, was developed to examine future acceptance with its determinants and intention to use the AP. One hundred thirty-two patients with diabetes type 1 treated with insulin pump therapy completed the questionnaire. Using factor analysis and reliability analysis, the number of items was reduced from 34 to 15.
  
  
  RESULTS
  The response rate was 66%. The subjects had a mean age of 43 years, and 34% were male. Almost 75% had the intention to use an AP. There were high scores on perceived usefulness (expected improvement of glucose control: 35.6% moderately agreed and 53% strongly agreed), perceived ease of use (expectation that the AP can be easily handled: 33.3% moderately agreed and 53.8% strongly agreed), and trust (administration of correct insulin dose and reliability of glucose measurement: 40.9% and 38.9% moderately agreed, whereas 32.6% and 28.2% strongly agreed, respectively).
  
  
  CONCLUSIONS
  A newly developed questionnaire examining the acceptance of an AP indicated that most patients with continuous subcutaneous insulin infusion-treated type 1 diabetes have the intention to use an AP system and have a positive attitude toward perceived usefulness, ease of use, and trust.
authors.affiliation: Department of Internal Medicine, Academic Medical Center Amsterdam, Amsterdam, The Netherlands. a.c.vanbon@amc.nl
authors.forename: Arianne C
authors.initials: AC
authors.lastname: van Bon
authors.forename: Terry B
authors.initials: TB
authors.lastname: Brouwer
authors.forename: Golo
authors.initials: G
authors.lastname: von Basum
authors.forename: Joost B L
authors.initials: JB
authors.lastname: Hoekstra
authors.forename: J Hans
authors.initials: JH
authors.lastname: DeVries
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D019397:Pancreas, Artificial / Q000523:psychology*; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D010865:Pilot Projects; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin